capital
Biotech Startup Investment Held Steady Even As AI Funding Surged
August 31, 2026
Biotech startup funding has stayed unusually steady at roughly $36 billion to $40 billion globally for the past few years and is tracking near that range in 2026, even as overall venture investment hit a record in H1 2026. More than $6 billion has gone to AI-focused biotechs this year, led by Isomorphic Labs’ $2.1 billion Series B, but most biotech rounds are still seed and early stage, with a busy mix of IPOs and at least 12 billion-dollar M&A exits.
This is a summary. Read the full story at news.crunchbase.com — all reporting credit belongs to the original publisher.